Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency

Figure 1

Phenotype of cells collected after immature dendritic cell preparation procedure in cancer patients. Peripheral blood mononuclear cells from healthy donors (n = 11) or patients with colorectal cancer (n = 7), renal cell carcinoma (n = 10), or breast cancer (n = 15) were depleted of lymphocytes (2-hour adherence step) and cultured for 7 days in the presence of granulocyte–macrophage colony-stimulating factor and IL-4. Data are expressed as the percentage of cells (with standard error) expressing the HLA-DR+Lin- and HLA-DR-Lin- phenotype. *P < 0.01 versus healthy donors.

Back to article page
\